Several retrospective studies associated the drug class with lower glaucoma risk and reduced ocular hypertension incidence, while preclinical work demonstrated reduced retinal ganglion cell loss and optic nerve damage in experimental models. The experimental literature also points to inflammatory modulation, oxidative stress reduction and retinal ganglion cell survival pathways as possible mechanisms. Smaller studies evaluating IIH and DED reported reductions in intracranial pressure and improved ocular surface parameters, respectively, among treated patients. READ MORE: Blinding Disease-Weight Loss Drug Link: EMA Announces Start of Semaglutide Investigation The evidence base still has limits The review flagged recurring methodological constraints across the literature: reliance on retrospective EHR analyses and ICD-based coding, heterogeneous ocular endpoints, inconsistent imaging and limited longitudinal follow-up
Jeremy London Board Certified Cardiovascular Surgeon, Rho Partner Rho products are built on advanced delivery technology , grounded in science, and a simple addition to my daily routine
Then, based on the randomization program, the nurse distributed colored syrups to the patients by assigning an identification code to each patient
The sample size was determined based on a priori power analysis using G*Power software using a moderate effect size at an alpha error probability of 0.05 [82]
L-carnitine is involved in fatty acid metabolism, transporting fatty acid chains into the mitochondrial matrix, allowing cells to obtain energy
Sept 11: Israelbased BioLineRx won FDA approval for Aphexda (motixafortide), a stem cell mobilization agent for patients with multiple myeloma scheduled for autologous stem cell transplantation (ASCT)
